Human Epidermal Growth Factor Receptor 2 | Protein Tyrosine Kinase/RTK| CSNpharm

HER2

HER2
第页，共 1 页

货号	产品名	CAS号	信息
CSN16336	XL647	781613-23-8	XL647 or tesevatinib inhibits EGFR, HER2, VEGFR and EphB4 with potential antineoplastic activity.
CSN12170	Tyrphostin AG 879	148741-30-4	Tyrphostin AG 879 potently inhibits HER2/ErbB2 with IC50 of 1 μM, 100- and 500-fold higher selective to ErbB2 than PDGFR and EGFR.
CSN20576	Neratinib Maleate	915942-22-2	Neratinib maleate is an orally available, irreversible tyrosine kinase inhibitor with IC50 of 59 nM and 92 nM for HER2 and EGFR, respectively.
CSN12420	Neratinib	698387-09-6	Neratinib is an orally available, irreversible tyrosine kinase inhibitor with IC50 of 59 nM and 92 nM for HER2 and EGFR, respectively.
CSN11269	Lapatinib Ditosylate	388082-77-7	Lapatinib ditosylate is a potent EGFR and ErbB2 inhibitor with IC50 of 10.8 and 9.2 nM, respectively.
CSN10535	Canertinib 2HCl	289499-45-2	Canertinib 2HCl, an irreversible quinazoline-based HER family tyrosine kinase inhibitor, inhibits EGFR and ErbB2 with IC50 of 1.5 nM and 9.0 nM respectively. Phase II.